Skip to Content
Merck
CN
  • Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.

Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.

The Journal of biological chemistry (2014-05-24)
Nickie C Chan, Willem den Besten, Michael J Sweredoski, Sonja Hess, Raymond J Deshaies, David C Chan
ABSTRACT

Because the deubiquitinating enzyme USP33 is involved in several important cellular processes (β-adrenergic receptor recycling, centrosome amplification, RalB signaling, and cancer cell migration), its levels must be carefully regulated. Using quantitative mass spectrometry, we found that the intracellular level of USP33 is highly sensitive to the activity of p97. Knockdown or chemical inhibition of p97 causes robust accumulation of USP33 due to inhibition of its degradation. The p97 adaptor complex involved in this function is the Ufd1-Npl4 heterodimer. Furthermore, we identified HERC2, a HECT domain-containing E3 ligase, as being responsible for polyubiquitination of USP33. Inhibition of p97 causes accumulation of polyubiquitinated USP33, suggesting that p97 is required for postubiquitination processing. Thus, our study has identified several key molecules that control USP33 degradation within the ubiquitin-proteasome system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-USP33 antibody produced in mouse, clone 5B5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-Actin Antibody, clone C4, ascites fluid, clone C4, Chemicon®
Sigma-Aldrich
ANTI-FLAG® M2-Peroxidase (HRP) antibody, Mouse monoclonal, clone M2, purified immunoglobulin, buffered aqueous glycerol solution